The invention relates to a dendrimer-type macromolecular structure comprising a dendrimer with at least one dye encapsulated therein.
The present invention relates to dendrimer synthesis.
The dendrimer lowers the irritation potential of the surfactant.
A dendrimer useful in the synthesis of the fractal-like compound includes a single ligating moiety bound to a surface of each quadrant of the dendrimer.
A nanodevice composition including N-acetyl cysteine linked to a dendrimer, such as a PAMAM dendrimer, is provided.
The polyamine used in the ink composition of the present invention includes a dendrimer.
Provided is a dendrimer particle having a unit that contains a fluorine atom at a plurality of branch ends of an aliphatic branched polymer (dendrimer).
A substrate having a dendrimer monolayer film thereon is provided.
An article having: one or more paramagnetic microbeads; a dendrimer molecule bound to the beads; and a probe nucleic acid immobilized to the dendrimer.
Preparation of a dendrimer is shown in Fig. 1/5.
The composition includes a metal ion, a borate ion, a borate ion- complexing species, and a dendrimer, wherein the dendrimer is readily emulsifiable by an anionic dispersant.
These conjugates have particularly advantageous properties due to the unique characteristics of the dendrimer.
First, the carbohydrate is bound to the dendrimer in a chemoselective manner.
The noble metal nanoclusters are preferably encapsulated by a dendrimer or a peptide.
The articles have a dendrimeric material attached to a substrate.
There is provided a nanodevice composition for localizing and delivering therapeutically active agents, the nanodevice includes a PAM AM dendrimer and at least one therapeutically active agent attached to the PAM AM dendrimer.
In one embodiment a labile internal standard sensitive to heat or protease is used together with the dendrimer standard.
A process for making a substantially saturated dendritic hydrocarbon polymer.
An aqueous dispersible hydroxyl-functional dendrimer polymer composition.
A method of increasing the bioavailability of a drug includes bonding the drug to a dendrimer of the invention.
Requêtes fréquentes français :1-200, -1k, -2k, -3k, -4k, -5k, -7k, -10k, -20k, -40k, -100k, -200k, -500k, -1000k,
Requêtes fréquentes anglais :1-200, -1k, -2k, -3k, -4k, -5k, -7k, -10k, -20k, -40k, -100k, -200k, -500k, -1000k,
Traduction Translation Traducción Übersetzung Tradução Traduzione Traducere Vertaling Tłumaczenie Mετάφραση Oversættelse Översättning Käännös Aistriúchán Traduzzjoni Prevajanje Vertimas Tõlge Preklad Fordítás Tulkojumi Превод Překlad Prijevod 翻訳 번역 翻译 Перевод